TXG (10x Genomics, Inc. Class A Common Stock) Stock Analysis - Politician Trades
10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of May 21, 2026, TXG trades at $23.98 with a market cap of $2.72B and a P/E ratio of -137.82. TXG moved +7.58% today. Year to date, TXG is +30.90%; over the trailing twelve months it is +164.10%. Its 52-week range spans $6.78 to $26.45. Analyst consensus is buy with an average price target of $24.10. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded TXG stock?
Rallies tracks politician and congressional stock disclosures for TXG, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Rallies tracks politician and congressional stock disclosures for TXG, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in TXG?
Yes. Rallies tracks politician and congressional stock disclosures for TXG, including reported purchases, sales, dates, owners, and trade amounts when available.
Is TXG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TXG. It does not provide personalized investment advice.
